Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia. [electronic resource]
Producer: 20210705Description: 94-103 p. digitalISSN:- 2159-3345
- Adult
- Aged
- Amyloid Neuropathies, Familial -- drug therapy
- Female
- Genetic Predisposition to Disease
- Humans
- Immune System Diseases -- chemically induced
- Immunoglobulin G
- Intracranial Hemorrhages -- chemically induced
- Male
- Middle Aged
- Oligodeoxyribonucleotides, Antisense -- administration & dosage
- Oligonucleotides -- administration & dosage
- Oligonucleotides, Antisense -- administration & dosage
- Quality of Life
- Thrombocytopenia -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.